Login to Your Account

Pharma: In the clinic

Tuesday, June 10, 2014
Alk-Abello A/S, of Horsholm, Denmark, presented positive trial results on its new sublingual allergy immunotherapy tablet (SLIT-tablet) for house dust mite (HDM) respiratory allergic diseases at the 2014 Annual Congress of the European Academy of Allergy and Clinical Immunology (EAACI) in Copenhagen.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription